Results 31 to 40 of about 4,071 (233)

Efficacity and Safety of the Fluocinolone Acetonide Implant in Uveitic Macular Edema: A Real-Life Study from the French Uveitis Network. [PDF]

J Pers Med
Purpose: To evaluate the safety and efficacy of the fluocinolone acetonide implant (FAi, Iluvien® Horus pharma, Nice, France) in non-infectious uveitic macular edema (UME) and to approach the predictive factors of treatment response.
Jabbour M, Kodjikian L, Bourdin A, Rougier MB, Serrar Y, Weber M, Massé H, Mazhar D, Perez-Roustit S, Chiquet C, Delyfer MN, Bodaghi B, Touhami S.   +12 more
europepmc   +2 more sources

Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy. [PDF]

Ophthalmol Ther, 2023
Introduction Postoperative cystoid macular edema (PCME) is a complication of several ocular procedures, including pars plana vitrectomy (PPV), due to the activation of the inflammatory cascade.
Lima-Fontes M, Leuzinger-Dias M, Barros-Pereira R, Fernandes V, Falcão M, Falcão-Reis F, Rocha-Sousa A, Alves-Faria P.   +7 more
europepmc   +2 more sources

Efficacy of fluocinolone acetonide implant in diabetic macular edema patients previously treated with dexamethasone implant: A systematic review and meta-analysis. [PDF]

Pak J Med Sci
Background & Objective: Several diabetic macular edema (DME) patients are resistant to anti-vascular endothelial growth factors (VEGF) injections and are treated with corticosteroid implants.
Hu W, Ni L, Ying H, Zhang Z, Tu S, Tao Y, Chen L.   +6 more
europepmc   +2 more sources

Fluocinolone Acetonide Implant for Uveitis: Dissecting Responder and Non-Responder Outcomes at a Tertiary Center. [PDF]

Biomedicines
Macular edema (ME) remains a primary cause of visual deterioration in uveitis. Visual acuity (VA) can often be maintained using corticosteroid depot systems.
Abu Arif J, Knecht VA, Rübsam A, Lussac V, Jami Z, Pohlmann D, Müller B, Pleyer U.   +7 more
europepmc   +2 more sources

Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report. [PDF]

Case Rep Ophthalmol, 2022
Diabetic macular edema (DME) is now a well-known condition for which a number of treatments have been shown to be effective. Intraocular corticosteroids are part of this therapeutic arsenal but are sometimes responsible for ocular hypertension.
Rezkallah A, Loria O, Mathis T, Chacun S, Denis P, Kodjikian L.   +5 more
europepmc   +2 more sources

Sustained Delivery Fluocinolone Acetonide Vitreous Implants

Ophthalmology, 2014
José Cunha-Vaz, Raymond Iezzi, Peter A Campochiaro   +2 more
exaly   +2 more sources

Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema. [PDF]

Pharmaceutics, 2022
To predict the need for additional local corticosteroids after receiving the 0.19 mg fluocinolone acetonide (FAc) implant in patients with macular edema secondary to non-infectious uveitis previously treated with local peribulbar corticosteroids.
Kessler LJ, Łabuz G, Auffarth GU, Khoramnia R.   +3 more
europepmc   +2 more sources

Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema - A Single Center Study. [PDF]

Clin Ophthalmol
Purpose To report the long-term functional, anatomical and safety outcomes of 0.2 μg/day fluocinolone acetonide 0.19mg in patients with persistent or recurrent diabetic macular edema (DME).
Soares RM, Ferreira CC, Fernandes JDS, Madeira C, Silva LMA, Saraiva E, Ribeiro L, Fonseca S.   +7 more
europepmc   +2 more sources

Extended real-world experience with the ILUVIEN® (fluocinolone acetonide) implant in the United Kingdom: 3-year results from the Medisoft® audit study. [PDF]

Eye (Lond), 2022
This study aimed to assess the long-term effectiveness of the 0.2 μg/day fluocinolone acetonide (FAc) implant over ≥3 years for patients with diabetic macular oedema.
Bailey C, Chakravarthy U, Lotery A, Menon G, Talks J, Medisoft Audit Group.   +5 more
europepmc   +2 more sources

Clinical impact of the 0.2 µg/day fluocinolone acetonide intravitreal implant: outcomes from the ILUVIEN clinical evidence study in Portugal

Therapeutic Advances in Ophthalmology, 2020
Introduction: The ILUVIEN ® (fluocinolone acetonide) Clinical Evidence in Portugal (ICE-PT) study is a retrospective, multicenter, observational study evaluating the effectiveness and safety of the FAc implant in patients with diabetic macular edema ...
Angela Carneiro, Angelina Meireles, João Paulo Castro Sousa, Carla Teixeira   +3 more
doaj   +1 more source